SecBot SecBot
DEFA14A ·Filed Oct 27, 2026

AYTU

AYTU BIOPHARMA, INC
NEUTRAL
Impact 2/10
Processed4h 46m ago SEC0001437749-26-033652
Proxy solicitation materials

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001437749-26-033652
Document: 0001437749-26-033652-index-headers.html0001437749-26-033652
Document: 0001437749-26-033652-index.html0001437749-26-033652
Document: 0001437749-26-033652.txt0001437749-26-033652
5 reports for AYTU
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AYTU — sortable, filterable
TypeNow
Oct 27, 2026
today
DEFA14A
NEUTRAL ★ 2/10
$1.94awaiting T+20—$1.93 (−0.52%)
Oct 22, 2026
5d ago
DEF 14A
NEUTRAL ★ 4/10
$1.90awaiting T+20—$1.93 (+1.58%)
Sep 22, 2026
5w ago
8-K
BULLISH ★ 6/10
$2.28 $1.96▼ −14.04%▼ −14.72%$1.93 (−15.35%)
Jun 25, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$2.17 $2.16▼ −0.46%▼ −1.72%$1.93 (−11.06%)
Apr 2, 2026
29w ago
8-K
BEARISH ★ 7/10
$2.66 $2.55▲ +4.14%▲ +13.12%$1.93 (+27.44%)
Showing 5 of 5

US Market Status

Market Closed — Opens Thu (12h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 27, 2026

Fresh AYTU Intelligence

Analysis is for subscribers only.

Subscribe for Full Access